Electromed GAAP EPS of $0.32 beats by $0.06, revenue of $18.7M misses by $0.15M
At a glance
- $ELMD today+0.13%last $23.13
- Vs industry peers+1.25 pts6-peer median −1.12% · ahead
- Since Nov 10−14.3%from the first trade after the story
- 52-week range2.0% above low$22.67 – $47.40
- Last reported profit$2.8Mquarter to Sep 30, 2026 · 10-Q
- In the headline$0.32Amount
Nothing reported about electromed across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: The headline zeroes in on one number — $0.32 — but the real story lies in how it stacks up against expectations and what the company is saying about the road ahead.
- How the stock is trading: $ELMD +0.13% in the latest session.
- Timing: It was published after the close, so the day's move was settled before the story existed. The next session is the first that could react.
Where the stock stands
Electromed ($ELMD) edged up 0.13% to $23.13 in the latest session. Over the past month it is down 15.6%. That leaves it 51% below its 52-week high of $47.40 and 2.0% above its low of $22.67, close to the bottom of its range. It has been a volatile year: the high was 2.1 times the low, so moves this size are not unusual for it.
What the filings say
In its latest report (10-Q, filed Nov 10, 2026), $ELMD earned $2.8M over the quarter to Sep 30, 2026 on revenue of $18.7M. Operations brought in $373K of cash over the quarter to Sep 30, 2026; after capital spending, free cash flow was $208K. Total liabilities were $8.6M against $15.9M of cash on Sep 30, 2026. The company filed an 8-K — the form for material events — on Nov 10, the same day as this story; it is $ELMD's own account and the first thing to read. Figures are as filed with the SEC; the $ELMD page has the full statements.
How much coverage it is getting
This is one of 2 stories on Electromed in Wook's last 30 days of coverage, including 1 this week. That is well above its usual pace: over the month it has averaged less than one a week. Going by their wording, 0 read bullish, 2 neutral and 0 bearish. This one reads neutral too, in line with most of them. 2 came from Seeking Alpha and the rest from other outlets, so more than one newsroom is on it.
The bigger picture
Earnings reports are less about the numbers and more about the narrative. A beat with poor guidance can feel like a miss, while a miss with positive signs can feel like a win — it's all about the context. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
The $ELMD page has the full chart, filings, and models to dig deeper. Since one outlet dominates the coverage, checking another can help confirm the story or spot repetition. Wook AI can pull live data and run the numbers on request — how far $ELMD is from its high, or how this week's coverage stacks up.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 10, 2026. $ELMD has moved -14.33% ($27.00 to $23.13). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
